|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | CSD00225 |
| 保存条件 | store at -80℃ |
| 用途 | 仅用于科研用途 |
| 应用范围 | |
| 抗原来源 | CHO cells |
| CAS编号 | 1011710-99-8 |
| 保质期 | 一年 |
| 抗体名 | Iodine (124I) Girentuximab ( 碘[124I]吉妥昔单抗 ) |
| 是否单克隆 | |
| 克隆性 | |
| 靶点 | CA9[Homo sapiens] |
| 适应物种 | |
| 形态 | |
| 宿主 | |
| 标记物 | |
| 包装规格 | 1mg/ml |
| 纯度 | % |
| 亚型 | |
| 标识物 | |
| 浓度 | 95% |
| 免疫原 | |
| 是否进口 | 否 |
Girentuximab I-124 is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).
货号（Catalog No.）
CSD00225
通用名INN
Iodine (124I) Girentuximab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Girentuximab I-124 is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).
别名(Alternative names)
124I_WX-G250,124I_cG250
靶点;物种(Specificity target name;species)
CA9[Homo sapiens]
种类(Species)
Chimeric
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
CAS
1011710-99-8
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
